Menu
A new Government Accountability Office report recommended that HHS identify and implement ways to formally coordinate activities relating to drug shortages—particularly, with a key position that oversees such actions set to end next month.

GAO Report Finds HHS Must Do More to Address Drug Shortages, Doesn’t Mention 340B as a Factor

Shannon Young, Associate Editor/Senior Writer 340B Report Views
The U.S. Department of Health and Human Services (HHS) should identify and implement ways to formally coordinate activities relating to [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

Post Navigation

Merck Exempts Three More States from 340B Restrictions, Novartis Sues Utah Over Contract Pharmacy Access Law

Webinar—Neutral 340B Clearinghouse: Now Live

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Site Footer Live